A questionnaire-based study to assess the status and perspective of fixed-dose combination among the various stakeholders including regulators, clinicians, researchers, and industry

A questionnaire-based study to assess the status and perspective of fixed-dose combination among the various stakeholders including regulators, clinicians, researchers, and industry

Fixed-dose combinations (FDCs) dominating the global market because of better compliance. However, irrational combination can lead to human-made menace in terms of development of resistance, tolerance, drug abuse, and economy encumbrance. The US Food and Drug Administration defines a combination pro...

Full description

Bibliographic Details
Main Authors: Krishan Kumar Bhardwaj, K Bangarurajan, Tanveer Naved, Satyendra Kumar Rajput
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Advanced Pharmaceutical Technology & Research
Subjects:
Act
approved combinations
Central Drugs Standard Control Organization
court
drugs
new drugs
nonapproved fixed dose combination
Rule 122D
Rule 122E
Rule 21
Online Access:http://www.japtr.org/article.asp?issn=2231-4040;year=2019;volume=10;issue=3;spage=138;epage=142;aulast=Bhardwaj

Internet

http://www.japtr.org/article.asp?issn=2231-4040;year=2019;volume=10;issue=3;spage=138;epage=142;aulast=Bhardwaj

Similar Items